Dersalazine

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameDersalazine
Drug Alias Name德沙拉秦dersalazinumdersalazinedersalazinaUR-12746
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPlatelet-activating factor inhibitors
TargetsPlatelet-activating factor
Therapy Area/IndicationsColitis, Ulcerative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumSlovakiaHungary +[4] 
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesUriach
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPalau Pharma SLU
Active IndicationsN/A
Inactive IndicationsColitis, Ulcerative

Other Information

ATC CodeN/A
Related LinksN/A